LUMIRATEK
DEAD

Serial Number

79192812

Owner

LumiraDX International Ltd

Attorney

Timothy M. Kenny

Filing Date

Feb 22, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LUMIRATEK Trademark

Serial Number: 79192812 • Registration: 5268376

LUMIRATEK is a trademark filed by LumiraDX International Ltd on February 22, 2016. The trademark is classified under Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

LumiraDX International Ltd (12 trademarks)

London SE12AQ , GB

Entity Type: 99

Roche Diagnostics International AG (3 trademarks)

Forrenstrasse 2

Entity Type: 98

Trademark Details

Filing Date

February 22, 2016

Registration Date

August 22, 2017

Published for Opposition

June 6, 2017

Cancellation Date

March 8, 2024

Goods & Services

Compilation of medical reports into computer databases

Healthcare services; medical services; medical diagnostic testing and reporting services; providing medical information, consultation and advisory services; consulting services in the field of health; medical consulting regarding medical diagnostic apparatus and instruments; medical consulting regarding diagnostic preparations; surgical diagnostic services; advice relating to the medical needs of elderly people; providing medical advisory services relating to medical instruments; providing medical advisory services relating to medical services; conducting of medical examinations; medical analysis services, namely, providing medical record analysis and assessment services designed to provide patients and healthcare professionals with customized diagnostic information, patient diagnoses, medical treatment plans and healthcare management plans; medical examination of individuals; medical health assessment services; medical screening; medical services for the diagnosis of conditions of the human body; medical testing for diagnostic purposes; surgical diagnostic services; health and medical services delivered via online interactive database enabling medical device users to exchange information with healthcare providers; and advice, consultancy and information on the aforesaid, included in the class

Diagnostic, examination and monitoring equipment for medical purposes, namely, apparatus for the detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; medical diagnostic apparatus for the detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse medical diagnostic instruments for detecting chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; diagnostic instruments for medical use for the testing and analysis of assays; electronic apparatus for medical purposes for the monitoring of glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; analytical instruments for medical use, namely device for monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; apparatus for carrying-out diagnostic tests for medical purposes, namely measurement and detection of glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; medical apparatus for monitoring vital signs; apparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, diabetes, cancer, women's health including pregnancy, sexually transmitted diseases, hematology and drugs of abuse; diagnostic imaging apparatus for medical use; diagnostic measuring apparatus for medical use, namely device for monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, and vital signs, blood counts and blood analysis; apparatus for blood analysis for medical purposes; medical instruments for drug abuse testing; medical imaging apparatus; medical apparatus for detecting drugs of abuse; medical apparatus for detecting and measuring the level of substances in bodily fluids; and parts and fittings for all the aforesaid goods, included in the class

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Dec 21, 2024 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Nov 26, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 26, 2024 XXCR
CHANGE OF OWNER RECEIVED FROM IB
Nov 22, 2024 CHLD
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 9, 2024 INTR
CANCELLED SECTION 71
Mar 8, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 22, 2022 REM3
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jul 13, 2021 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Jul 3, 2021 RHRD
NEW REPRESENTATIVE AT IB RECEIVED
Dec 20, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 22, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 6, 2017 FICS
FINAL DISPOSITION PROCESSED
Dec 6, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 22, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 22, 2017 R.PR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jul 19, 2017 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Jul 7, 2017 RHRD
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2017 TROA
REFUSAL PROCESSED BY IB
Nov 18, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 3, 2016 RFCS
REFUSAL PROCESSED BY MPU
Nov 3, 2016 RFRR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 30, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 30, 2016 REAP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 13, 2016 RFCR
NON-FINAL ACTION WRITTEN
Oct 12, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 11, 2016 MAFR
ASSIGNED TO EXAMINER
Oct 6, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 1, 2016 REPR